0 items USD 0.00Search
Your search for "qyresearch global kinase inhibitors cancer treatment consumption 2016 market research report" gave back 758464 results.
The global BTK Inhibitor market size was valued at USD 911.6 million in 2022 and is forecast to a readjusted size of USD 1825.9 million by 2029 with...
Catalog:
GIR
July 2023
Price: USD 3,480.00
BTK inhibitors are able to interfere with cell signaling cascades and prevent key phosphorylations in B cells, therefore preventing or reducing...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global Bruton's Tyrosine Kinase (BTK) Inhibitors market size was valued at US$ 8870.6 million in 2023. With growing demand in downstream...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Cabozantinib, sold under the brand-name Cabometyx and Cometriq, is a medication used to treat medullary thyroid cancer and a second line treatment...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Brutons Tyrosine Kinase Inhibitor market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Highlights The global Bruton’s Tyrosine Kinase (BTK) Inhibitor market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The global Cyclin-Dependent Kinase (CDK) Inhibitors market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
The global FMS-like Tyrosine Kinase 3 Inhibitors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The global Bruton’s Tyrosine Kinase (BTK) Inhibitors market was valued at US$ 9700 million in 2022 and is anticipated to reach US$ 16620 million by...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Bruton’s Tyrosine Kinase (BTK) Inhibitor market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
BTK inhibitors are able to interfere with cell signaling cascades and prevent key phosphorylations in B cells, therefore preventing or reducing...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Chemotherapy is systemic drug treatment intended to stop cancer cells from dividing and growing. Many different types of chemotherapy drugs are used...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
New anti-tumor targets and corresponding new anti-tumor agents or means are: targeting cell signal transduction molecules, including protein tyrosine...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
The global BTK Inhibitor market size is projected to grow from US$ 866.7 million in 2022 to US$ 1834.6 million in 2029; it is expected to grow at a...
Catalog:
LPI
June 2023
Price: USD 3,660.00
